VOYAGER: An open-label, randomised, phase 3 study of avapritinib vs regorafenib in patients with locally advanced metastatic or unresectable gastrointestinal stromal tumour Meeting Abstract
| Authors: | Bauer, S.; George, S.; Kang, Y.; Jones, R.; Mir, O.; Tap, W.; Doyle, A.; Picazio, N.; Zhou, T.; Roche, M.; Heinrich, M. |
| Abstract Title: | VOYAGER: An open-label, randomised, phase 3 study of avapritinib vs regorafenib in patients with locally advanced metastatic or unresectable gastrointestinal stromal tumour |
| Meeting Title: | ESMO 21st World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 30 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2019 Jul 3-6 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-07-01 |
| Start Page: | mdz155.196 |
| Language: | English |
| ACCESSION: | WOS:000475860200206 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdz155.196 |
| Notes: | Meeting Abstract: P-197 -- Appears on page iv54 of the abstract book -- Source: Wos |
